ArticleFrontiers in oncology2022

Pro-Inflammatory and Pro-Oxidative Changes During Nilotinib Treatment in CML Patients: Results of a Prospective Multicenter Front-Line TKIs Study (KIARO Study).

Anna Sicuranza et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.